Showing results (1-10 of 707) with videos related to

Sort By:
Pageof 71
Familial Cancer|July 25, 2013
Chemoprevention in Lynch syndromeJohn Burn, John C Mathers, D Tim Bishop
Annals of Human Genetics|September 24, 2010
MLH1 Differential allelic expression in mutation carriers and controlsMauro Santibanez Koref, Valerie Wilson, Nicola Cartwright, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 6, 2011
A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposisJohn Burn, D Timothy Bishop, Pamela D Chapman, et al.
The Proceedings of the Nutrition Society|May 13, 2003
Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 StudyJohn C Mathers, Ian Mickleburgh, Pam C Chapman, et al.
Melanoma Research|May 20, 2016
Psychosocial, clinical and demographic features related to worry in patients with melanomaZoe Rogers, Faye Elliott, Nadine A Kasparian, et al.
BMC Medical Genetics|July 22, 2008
Analysis of variants in DNA damage signalling genes in bladder cancerAnanya Choudhury, Faye Elliott, Mark M Iles, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 15, 2013
Do vitamin A serum levels moderate outcome or the protective effect of vitamin D on outcome from malignant melanoma?Sinead Field, Faye Elliott, Juliette Randerson-Moor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 25, 2022
Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-upJohn C Mathers, Faye Elliott, Finlay Macrae, et al.
Pageof 71